Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Berk

Showing results (221-230 of 1,307) with videos related to

Pageof 131
Sort By:
Drug and Alcohol Review|July 15, 2009
Client-reported reasons for non-engagement in drug and alcohol treatmentCarolyn Coulson, Felicity Ng, Marjan Geertsema, et al.
CNS Drugs|April 11, 2012
Minocycline: therapeutic potential in psychiatryOlivia M Dean, João Data-Franco, Francesco Giorlando, et al.
Brain and Behavior|June 21, 2013
How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathwaysSteven Moylan, Felice N Jacka, Julie A Pasco, et al.
Current Opinion in Psychiatry|November 26, 2013
Antidepressant pharmacogeneticsAjeet B Singh, Chad A Bousman, Chee Ng, et al.
Clinical Rehabilitation|August 28, 2014
The association between attributions of responsibility for motor vehicle accidents and patient satisfaction: a study within a no-fault injury compensation systemJason Thompson, Michael Berk, Meaghan O'Donnell, et al.
The Australian and New Zealand Journal of Psychiatry|June 29, 2018
Ketamine and rapidly acting antidepressants: Breaking the speed of sound or light?Michael Berk, Collen Loo, Christopher G Davey, et al.
BMC Medicine|October 23, 2012
Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studiesSteven Moylan, Felice N Jacka, Julie A Pasco, et al.
Journal of Affective Disorders|December 15, 2011
Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depressionMichael Maes, Karl Ringel, Marta Kubera, et al.
Expert Opinion on Drug Safety|July 14, 2005
A review of clozapine safetyJoanna Fitzsimons, Michael Berk, Timothy Lambert, et al.
BMC Medicine|March 19, 2013
A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behaviorGerwyn Morris, George Anderson, Piotr Galecki, et al.
Pageof 131

Showing results (221-230 of 1,307) with videos related to

Sort By:
Pageof 131
Drug and Alcohol Review|July 15, 2009
Client-reported reasons for non-engagement in drug and alcohol treatmentCarolyn Coulson, Felicity Ng, Marjan Geertsema, et al.
CNS Drugs|April 11, 2012
Minocycline: therapeutic potential in psychiatryOlivia M Dean, João Data-Franco, Francesco Giorlando, et al.
Brain and Behavior|June 21, 2013
How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathwaysSteven Moylan, Felice N Jacka, Julie A Pasco, et al.
Current Opinion in Psychiatry|November 26, 2013
Antidepressant pharmacogeneticsAjeet B Singh, Chad A Bousman, Chee Ng, et al.
Clinical Rehabilitation|August 28, 2014
The association between attributions of responsibility for motor vehicle accidents and patient satisfaction: a study within a no-fault injury compensation systemJason Thompson, Michael Berk, Meaghan O'Donnell, et al.
The Australian and New Zealand Journal of Psychiatry|June 29, 2018
Ketamine and rapidly acting antidepressants: Breaking the speed of sound or light?Michael Berk, Collen Loo, Christopher G Davey, et al.
BMC Medicine|October 23, 2012
Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studiesSteven Moylan, Felice N Jacka, Julie A Pasco, et al.
Journal of Affective Disorders|December 15, 2011
Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depressionMichael Maes, Karl Ringel, Marta Kubera, et al.
Expert Opinion on Drug Safety|July 14, 2005
A review of clozapine safetyJoanna Fitzsimons, Michael Berk, Timothy Lambert, et al.
BMC Medicine|March 19, 2013
A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behaviorGerwyn Morris, George Anderson, Piotr Galecki, et al.
Pageof 131